Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution

被引:392
|
作者
House, Michael G. [1 ]
Ito, Hiromichi [1 ]
Gonen, Mithat [2 ]
Fong, Yuman [1 ]
Allen, Peter J. [1 ]
DeMatteo, Ronald P. [1 ]
Brennan, Murray F. [1 ]
Blumgart, Leslie H. [1 ]
Jarnagin, William R. [1 ]
D'Angelica, Michael I. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
关键词
LONG-TERM SURVIVAL; PORTAL-VEIN EMBOLIZATION; LIVER METASTASES; CURATIVE INTENT; EXTRAHEPATIC DISEASE; 2-STAGE HEPATECTOMY; 5-YEAR SURVIVAL; CHEMOTHERAPY; SURGERY; RECURRENCE;
D O I
10.1016/j.jamcollsurg.2009.12.040
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: This study analyzes factors associated with differences in long-term outcomes after hepatic resection for metastatic colorectal cancer over time. STUDY DESIGN: Sixteen-hundred consecutive patients undergoing hepatic resection for metastatic colorectal cancer between 1985 and 2004 were analyzed retrospectively. Patients were grouped into 2 eras according to changes in availability of systemic chemotherapy: era I, 1985 to 1998; era II, 1999 to 2004. RESULTS: There were 1,037 patients in era I and 563 in era II. Operative mortality decreased from 2.5% in era I to 1% in era II (p = 0.04). There were no differences in age, Clinical Risk Score, or number of hepatic metastases between the 2 groups; however, more recently treated patients (era II) had more lymph node positive primary tumors, shorter disease-free intervals, more extrahepatic disease, and smaller tumors. Median follow-up was 36 months for all patients and 63 months for survivors. Median and 5-year disease-specific survival (DSS) were better in era II (64 months and 51% versus 43 months and 37%, respectively; p < 0.001); but median and 5-year recurrence-free survival (RFS) for all patients were not different (23 months and 33% era II versus 22 months and 27% era I; p = 0.16). There was no difference in RFS or DSS for high-risk (Clinical Risk Score >2, n = 506) patients in either era. There was a marked improvement in both RFS and DSS for low risk (Clinical Risk Score 2, n = 1,094) patients. CONCLUSIONS: Despite worse clinical and pathologic characteristics, survival but not recurrence rates after hepatic resection for colorectal metastases have improved over time and might be attributable to improvements in patient selection, operative management, and chemotherapy. The improvement in survival over time is largely accounted for by low-risk patients. (J Am Coll Surg 2010; 210:744-754. (C) 2010 by the American College of Surgeons)
引用
收藏
页码:744 / 752
页数:9
相关论文
共 50 条
  • [1] Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution Discussion
    Hemming, Alan W.
    Choti, Michael A.
    Kooby, David A.
    Levine, Edward
    D'Angelica, Michael
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (05) : 752 - 754
  • [2] Clinical stage for predicting survival after hepatic resection for metastatic colorectal cancer
    Minagawa, M
    Kokudo, N
    Makuuchi, M
    GASTROENTEROLOGY, 2003, 124 (04) : A651 - A651
  • [3] Clinical stage for predicting survival after hepatic resection for metastatic colorectal cancer
    Minagawa, M
    Makuuchi, M
    GASTROENTEROLOGY, 2004, 126 (04) : A110 - A110
  • [4] External Validation of Two Nomograms for Predicting Patient Survival After Hepatic Resection for Metastatic Colorectal Cancer
    Yuji Takakura
    Masazumi Okajima
    Yukihide Kanemitsu
    Shintaro Kuroda
    Hiroyuki Egi
    Takao Hinoi
    Hirotaka Tashiro
    Hideki Ohdan
    World Journal of Surgery, 2011, 35 : 2275 - 2282
  • [5] External Validation of Two Nomograms for Predicting Patient Survival After Hepatic Resection for Metastatic Colorectal Cancer
    Takakura, Yuji
    Okajima, Masazumi
    Kanemitsu, Yukihide
    Kuroda, Shintaro
    Egi, Hiroyuki
    Hinoi, Takao
    Tashiro, Hirotaka
    Ohdan, Hideki
    WORLD JOURNAL OF SURGERY, 2011, 35 (10) : 2275 - 2282
  • [6] Improving treatment and survival: a population-based study of current outcomes after a hepatic resection in patients with metastatic colorectal cancer
    Zaydfudim, Victor M.
    McMurry, Timothy L.
    Harrigan, Amy M.
    Friel, Charles M.
    Stukenborg, George J.
    Bauer, Todd W.
    Adams, Reid B.
    Hedrick, Traci L.
    HPB, 2015, 17 (11) : 1019 - 1024
  • [7] Survival outcomes following primary tumor resection for patients with incurable metastatic colorectal carcinoma: Experience from a single institution
    Lau, Joel W. L.
    Chang, Heidi S. Y.
    Lee, Kai Y.
    Gwee, Yong X.
    Lee, Wen Q.
    Chong, Choon S.
    JOURNAL OF DIGESTIVE DISEASES, 2018, 19 (09) : 550 - 560
  • [8] Survival after hepatic resection in metastatic colorectal cancer - A population-based study
    Cummings, Linda C.
    Payes, Jonathan D.
    Cooper, Gregory S.
    CANCER, 2007, 109 (04) : 718 - 726
  • [9] Surgical resection and survival outcomes in metastatic young adult colorectal cancer patients
    Arhin, Nina D.
    Shen, Chan
    Bailey, Christina E.
    Matsuoka, Lea K.
    Hawkins, Alexander T.
    Holowatyj, Andreana N.
    Ciombor, Kristen K.
    Hopkins, Michael B.
    Geiger, Timothy M.
    Kam, Audrey E.
    Roth, Marc T.
    Lee, Cody M. Lebeck
    Lapelusa, Michael
    Dasari, Arvind
    Eng, Cathy
    CANCER MEDICINE, 2021, 10 (13): : 4269 - 4281
  • [10] A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer
    Kattan, Michael W.
    Goenen, Mithat
    Jarnagin, William R.
    DeMatteo, Ronald
    D'Angelica, Michael
    Weiser, Martin
    Blumgart, Leslie H.
    Fong, Yuman
    ANNALS OF SURGERY, 2008, 247 (02) : 282 - 287